Share this post on:

Product: GGTI298

KALRN RNAi Summary

Specificity
kalirin, RhoGEF kinase (KALRN), transcript variant 3, mRNA
Gene
KALRN

Applications/Dilutions

Application Notes
This RNAi causes protein knockdown.

Packaging, Storage & Formulations

Storage
Store at -20C. Avoid freeze-thaw cycles.

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for KALRN RNAi

  • ARHGEF24
  • DUETFLJ16443
  • DUO
  • EC 2.7.11.1
  • FLJ12332
  • FLJ18623
  • HAPIP
  • huntingtin-associated protein interacting protein (duo)
  • Huntingtin-associated protein-interacting protein
  • kalirin
  • kalirin, RhoGEF kinase
  • Protein Duo
  • serine/threonine kinase with Dbl- and pleckstrin homology domains
  • Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain
  • TRADFLJ18196

Background

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAis unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

PMID: 24381267

Share this post on:

Author: Potassium channel

Share this post on:

Product: SD-208

KALRN RNAi Summary

Specificity
kalirin, RhoGEF kinase (KALRN), transcript variant 1, mRNA
Gene
KALRN

Applications/Dilutions

Application Notes
This RNAi causes protein knockdown.

Packaging, Storage & Formulations

Storage
Store at -20C. Avoid freeze-thaw cycles.

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for KALRN RNAi

  • ARHGEF24
  • DUETFLJ16443
  • DUO
  • EC 2.7.11.1
  • FLJ12332
  • FLJ18623
  • HAPIP
  • huntingtin-associated protein interacting protein (duo)
  • Huntingtin-associated protein-interacting protein
  • kalirin
  • kalirin, RhoGEF kinase
  • Protein Duo
  • serine/threonine kinase with Dbl- and pleckstrin homology domains
  • Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain
  • TRADFLJ18196

Background

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAis unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

PMID: 18194435

Share this post on:

Author: Potassium channel